EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study

Yuki Etani, Takaaki Noguchi, Toshitaka Yukishima, Tomonori Kobayakawa, Masafumi Kashii, Gensuke Okamura, Atsushi Goshima, Makoto Hirao, Taihei Miura, Takuya Kurihara, Yuji Fukuda, Atsushi Sugimoto und 3 weitere

Bone · 2025-12 · 201 · 117627

DOI: 10.1016/j.bone.2025.117627 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Bone, 2025-12. Verfasst von Yuki Etani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Bone Density, Denosumab, Osteoporosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalBone DensityDenosumabOsteoporosisPeptide FragmentsProcollagenTeriparatideAgedAged, 80 and overFemaleHumansMaleMiddle AgedBone Density Conservation AgentsRetrospective StudiesCohort Studies

Stichwörter der Autor:innen

Bone mineral densityBone turnover markerDenosumabN-terminal type I procollagen propeptideRomosozumabTeriparatide

Substanzen

Antibodies, MonoclonalBone Density Conservation AgentsDenosumabPeptide FragmentsProcollagenprocollagen Type I N-terminal peptideromosozumabTeriparatide

Autor:innen und Institutionen

  • Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
  • Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
  • Department of Rheumatology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-Ku, Hamamatsu, Shizuoka, 430-8558, Japan.
  • Kobayakawa Orthopaedics and Rheumatologic Clinic, 1969 Kuno, Fukuroi, Shizuoka, 437-0061, Japan.
  • Department of Orthopaedic Surgery, National Hospital Organization, Osaka Minami Medical Center, Kawachinagano, 586-8521, Japan.
  • Department of Orthopaedic Surgery, Osaka Rosai Hospital, Sakai, 591-8025, Japan.

Zitieren

APA

Etani, Y., Noguchi, T., Yukishima, T., Kobayakawa, T., Kashii, M., Okamura, G., Goshima, A., Hirao, M., Miura, T., Kurihara, T., Fukuda, Y., Sugimoto, A., Okada, S., Nakata, K., & Ebina, K. (2025). Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study. Bone. https://doi.org/10.1016/j.bone.2025.117627

Vancouver

Etani Y, Noguchi T, Yukishima T, Kobayakawa T, Kashii M, Okamura G, et al. Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study. Bone. 2025. doi:10.1016/j.bone.2025.117627

BibTeX
@article{Etani2025,
  author = {Etani, Yuki and Noguchi, Takaaki and Yukishima, Toshitaka and Kobayakawa, Tomonori and Kashii, Masafumi and Okamura, Gensuke and Goshima, Atsushi and Hirao, Makoto and Miura, Taihei and Kurihara, Takuya and Fukuda, Yuji and Sugimoto, Atsushi and Okada, Seiji and Nakata, Ken and Ebina, Kosuke},
  title = {Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study},
  journal = {Bone},
  year = {2025},
  doi = {10.1016/j.bone.2025.117627}
}
Kostenlos starten →